News

Animal Free research UK is the leading medical charity in the UK that supports the replacement of the use of…

On September 4th, 2023, Startup Bubble news published an article featuring OrganoTherapeutics’ work. Startup Bubble is a news media platform…

KHAN-I obtains OrganoTherapeutics shares – KHAN Technology Transfer Fund I (KHAN-I) have invested in OrganoTherapeutics. – The venture fund, with…

OrganoTherapeutics made another step forward into business growth. We changed our company status in Luxembourg from SARL-S (Société à responsabilité…

Understanding how a specific molecule behaves during complex biological processes is a challenge facing biomedical research, despite major biotechnological progress…

Parkinson’s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment See our latest Publication Background The…

Together with colleagues from the Luxembourg Institute of Health (LIH) we were able to show that SARS-CoV2 can infect cells…

Fit 4 Start is an acceleration programme dedicated to high potential start-ups operating in the fields of Information and communications…

OrganoTherapeutics won the Rising Startup competition at Biovaria 2021 BioVaria Startup Awards go to iRASP Therapeutics and OrganoTherapeutics 30 April…

OrganoTherapeutics received support from the Luxembourgish Ministry of Economy for the project “Drug repurposing to target SARS-CoV-2 brain infection”. In…